Evidence supporting the efficacy of beta blockers in anxiety is reviewed. Propranolol and
oxprenolol are the most clearly established in efficacy. A placebo-controlled trial is …

Since 1964, of 725 patients presenting with anxiety syndromes, 513 were treated with
propranolol for periods of several days to over 10 years, some intermittently, others virtually …

An investigation of the effectiveness of the beta adrenoceptor blocking drug oxprenolol in
the treatment of primary clinical anxiety is reported. A controlled double‐blind evaluation of …

• In a double-blind crossover study the β-adrenergic blocking drug propranolol
hydrochloride reduced symptoms in 17 of 26 patients with chronic anxiety disorders. Both …

The therapeutic benefit of combining propranolol with diazepam over either of these drugs
given alone was tested in a placebo-controlled crossover study with twenty-four chronically …

The physiological correlates of anxiety include a number of cardiovascular and adrenergic
effects that are indicated by an increased blood level of adrenaline and noradrenaline …

The efficacy and safety of propranolol in the treatment of anxiety was compared with those of
chlordiazepoxide and placebo in a 3-week, double-blind study of 212 patients. After a 1 …

Carried out a 2-wk double-blind crossover study of propranolol HCl and placebo with 22
anxious psychiatric outpatients. Ss were instructed to increase the dose up to 160 mg daily …

The use of the broad range of antidepressant drugs in depression, panic agoraphobia, and
generalized anxiety is reviewed and the current ambiguous status of the benzodiazepines in …

The therapeutic value of propranolol and other beta-adrenergic receptor blockers in anxiety
disorders is reviewed. The potential side-effects of benzodiazepines, eg psychomotor …